Clinical Trial Update: An Open-label Study of GC012F in Rheumatoid Arthritis. [EARLY_Phase 1]

View source ↗

Summary

An open-label Phase 1 study of GC012F for rheumatoid arthritis is ongoing, with the trial status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• GC012F

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Rheumatoid Arthritis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING